What is Neochild?
NeoChild is a specialized developer of quality products designed to safeguard neonates and pediatric patients. With an extensive legacy spanning over 40 years in neonatal and IV therapy, the company offers a comprehensive range of products including safety enteral feeding systems, urinary catheters, IV extension sets, and custom convenience kits. NeoChild places a strong emphasis on on-shore production and maintaining sterility, which contributes to a robust supply chain and potential cost savings for healthcare providers. The company primarily serves hospitals and healthcare facilities seeking innovative solutions to enhance patient safety and care.
How much funding has Neochild raised?
Neochild has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Neochild?
The substantial expansion capital received by Neochild, indicative of a significant Series B/C stage, points towards an aggressive growth strategy. This financing is likely earmarked for enhancing manufacturing capabilities, expanding distribution networks, and potentially investing in research and development for next-generation medical devices. The company's focus on on-shore production and supply chain integrity will be crucial as it scales. Future developments may include strategic partnerships or further product line extensions to address evolving needs in neonatal and pediatric patient care, aiming to capture a larger share of the healthcare solutions market.
See full Neochild company page
